Zobrazeno 1 - 10
of 7 885
pro vyhledávání: '"Chronic migraine"'
Publikováno v:
Head & Face Medicine, Vol 20, Iss 1, Pp 1-6 (2024)
Abstract Background The International Classification of Headache Disorders (ICHD-3) uses moderate or severe pain intensity in the diagnostic criterion for migraine. However, few studies have analyzed pain rating on a visual analog scale to identify t
Externí odkaz:
https://doaj.org/article/533c009940c740e2a66e6cb0d6b59244
Autor:
Elizabeth A. Fall, Yang Chen, Jin-Mann S. Lin, Anindita Issa, Dana J. Brimmer, Lucinda Bateman, Charles W. Lapp, Richard N. Podell, Benjamin H. Natelson, Andreas M. Kogelnik, Nancy G. Klimas, Daniel L. Peterson, Elizabeth R. Unger, for the MCAM Study Group
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Chronic overlapping pain conditions (COPCs), pain-related conditions that frequently occur together, may occur in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and could impact illness severity. This st
Externí odkaz:
https://doaj.org/article/c609e5ef527946d89b732ed65a5de97e
Autor:
Tianxiao Wang, Chenlu Zhu, Kaibo zhang, Jinggui Gao, Yunhao Xu, Chenyang Duan, Shouyi Wu, Cheng Peng, Jisong Guan, Yonggang Wang
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-21 (2024)
Abstract Background Chronic migraine is a severe and common neurological disorder, yet its precise physiological mechanisms remain unclear. The IGF1/IGF1r signaling pathway plays a crucial role in pain modulation. Studies have shown that IGF1, by bin
Externí odkaz:
https://doaj.org/article/4d2b09aa9f464c8b8fced5cf3aaf5348
Autor:
Jinggui Gao, Da Wang, Chenlu Zhu, Jian Wang, Tianxiao Wang, Yunhao Xu, Xiao Ren, Kaibo Zhang, Cheng Peng, Jisong Guan, Yonggang Wang
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-16 (2024)
Abstract Background Chronic migraine is closely related to the dysregulation of neurochemical substances in the brain, with metabolic imbalance being one of the proposed causes of chronic migraine. This study aims to evaluate the metabolic changes be
Externí odkaz:
https://doaj.org/article/edcdb9b0b84d436aa105b7d4671a5942
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Efficacy and safety of human monoclonal antibody erenumab used for migraine prophylaxis have been shown in clinical studies. APOLLON is an open-label, multi-center, single arm study, which permits dose adjustments of erenumab and
Externí odkaz:
https://doaj.org/article/e6ecff1ce47745e68f685768d79638bf
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-9 (2024)
Abstract Background Chronic migraine is a debilitating neurological condition that significantly impairs both individual and socioeconomic outcomes. The aim of the present study was to estimate the remission rates of chronic migraine to episodic migr
Externí odkaz:
https://doaj.org/article/88777d07f2e94c8a9a0a0567eca1cf51
Autor:
Yu-Chin An, Kuo-Sheng Hung, Chih-Sung Liang, Chia-Kuang Tsai, Chia-Lin Tsai, Sy-Jou Chen, Yu-Kai Lin, Guan-Yu Lin, Po-Kuan Yeh, Fu-Chi Yang
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies have emerged as promising therapeutic options for the treatment of chronic migraine. However, treatment response varies considerably among individuals, suggesting a
Externí odkaz:
https://doaj.org/article/1877751684d042a188b9f77f476ec004
Publikováno v:
Head & Face Medicine, Vol 20, Iss 1, Pp 1-10 (2024)
Abstract Background Pulsed radiofrequency (PRF) treatment targeting the greater occipital nerve (GON) has shown efficacy in treating various conditions. This double-blind, randomized controlled study aimed to evaluate the effects of combining PRF the
Externí odkaz:
https://doaj.org/article/b82c1c1883fe4215925f4489d34bad28
Autor:
Gizem Gürsoy, Hale Arkan Tuna
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Migraine is a primary headache defined as moderate-to-severe pain lasting 4 to 72 h, ranking 2nd among the disabling conditions for both genders regardless of the age and the greater occipital nerve (GON) block has been reported a
Externí odkaz:
https://doaj.org/article/54253933422e4af6a30b49d5dfabc434
Autor:
Muhamad Saqlain Mustafa, Shafin bin Amin, Aashish Kumar, Muhammad Ashir Shafique, Syeda Mahrukh Fatima Zaidi, Syed Ali Arsal, Burhanudin Sohail Rangwala, Muhammad Faheem Iqbal, Adarsh Raja, Abdul Haseeb, Inshal Jawed, Khabab Abbasher Hussien Mohamed Ahmed, Syed Muhammad Sinaan Ali, Giustino Varrassi
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background & aims Chronic migraine poses a global health burden, particularly affecting young women, and has substantial societal implications. This study aimed to assess the efficacy of Greater Occipital Nerve Block (GONB) in individuals wi
Externí odkaz:
https://doaj.org/article/ff3bacceca494a0f99459425b5a1b55c